GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Norris Medicines Ltd

Norris Medicines Board Meeting to Approve Q2 FY27 Un-Audited Financial Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 06 Nov 2026, 11:33 AM IST  ·  BSE ID: d8282179-f078-4b23-ab7c-a3d93ca9ca99
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on November 14, 2026, to review and approve the latest financial performance report.
🤖 AI Summary
  • Norris Medicines Ltd Board Meeting scheduled for Saturday, November 14, 2026.
  • The primary agenda is to consider and approve un-audited financial results for Q2 FY27.
  • Results cover the quarter and half year ended September 30, 2026.
  • A Limited Review Report for the financial results will also be considered.
  • Trading window for company securities is closed from October 01, 2026 until 48 hours post-results.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders.
👤
Who Is Affected
All shareholders will be affected by the upcoming financial results, which will disclose the company's performance for Q2 FY27.
🔍
Management Signal
The scheduling of the board meeting indicates routine compliance with regulatory requirements for financial reporting.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Board Meeting Outcome on November 14, 2026 — for Q2 FY27 financial results.
Declaration of Q2 FY27 un-audited financial results — for performance data.
Trading window re-opening date — post Q2 FY27 results declaration.
LOW RISK The filing is a standard intimation of an upcoming board meeting, posing no immediate new risks.
💡 Investor Takeaway
Norris Medicines Ltd will hold a Board Meeting on November 14, 2026, to approve its un-audited financial results for the quarter and half year ended September 30, 2026 (Q2 FY27). These results will provide the first update on the company's financial performance.
📅 Company Track Record
No previous filings were found for Norris Medicines Ltd, indicating limited public track record information available.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is the Board Meeting of Norris Medicines Ltd scheduled?
The Board Meeting of Norris Medicines Ltd is scheduled for Saturday, November 14, 2026, at the Registered office.
What is the primary agenda for the Norris Medicines Ltd Board Meeting on November 14, 2026?
The primary agenda is to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2026, along with the Limited Review Report.
What is the status of the trading window for Norris Medicines Ltd shares?
The trading window for Norris Medicines Ltd securities is closed from October 01, 2026, and will remain closed until Forty-Eight (48) hours after the declaration of the un-audited financial results.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.